Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration: A Phase 1 Dose-Escalation Study.
Saved in:
| Title: | Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration: A Phase 1 Dose-Escalation Study. |
|---|---|
| Authors: | Jackson TL; School of Medicine, King's College London, London, United Kingdom., Boyer D; Retina-Vitreous Associates Medical Group, Beverly Hills, California., Brown DM; Blanton Eye Institute, Houston Methodist Hospital, Retina Consultants of Houston, Houston, Texas., Chaudhry N; New England Retina Associates, Guilford, Connecticut., Elman M; Elman Retina Group, Baltimore, Maryland., Liang C; Tyrogenex Inc, Rockville, Maryland., O'Shaughnessy D; Tyrogenex Inc, Rockville, Maryland., Parsons EC; Tyrogenex Inc, Rockville, Maryland., Patel S; Retina Research Institute of Texas, Abilene., Slakter JS; Digital Angiography Reading Center, New York, New York., Rosenfeld PJ; Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida. |
| Source: | JAMA ophthalmology [JAMA Ophthalmol] 2017 Jul 01; Vol. 135 (7), pp. 761-767. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print Cited Medium: Internet ISSN: 2168-6173 (Electronic) Linking ISSN: 21686165 NLM ISO Abbreviation: JAMA Ophthalmol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 28570723 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration: A Phase 1 Dose-Escalation Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jackson+TL%22">Jackson TL</searchLink>; School of Medicine, King's College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Boyer+D%22">Boyer D</searchLink>; Retina-Vitreous Associates Medical Group, Beverly Hills, California.<br /><searchLink fieldCode="AU" term="%22Brown+DM%22">Brown DM</searchLink>; Blanton Eye Institute, Houston Methodist Hospital, Retina Consultants of Houston, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Chaudhry+N%22">Chaudhry N</searchLink>; New England Retina Associates, Guilford, Connecticut.<br /><searchLink fieldCode="AU" term="%22Elman+M%22">Elman M</searchLink>; Elman Retina Group, Baltimore, Maryland.<br /><searchLink fieldCode="AU" term="%22Liang+C%22">Liang C</searchLink>; Tyrogenex Inc, Rockville, Maryland.<br /><searchLink fieldCode="AU" term="%22O'Shaughnessy+D%22">O'Shaughnessy D</searchLink>; Tyrogenex Inc, Rockville, Maryland.<br /><searchLink fieldCode="AU" term="%22Parsons+EC%22">Parsons EC</searchLink>; Tyrogenex Inc, Rockville, Maryland.<br /><searchLink fieldCode="AU" term="%22Patel+S%22">Patel S</searchLink>; Retina Research Institute of Texas, Abilene.<br /><searchLink fieldCode="AU" term="%22Slakter+JS%22">Slakter JS</searchLink>; Digital Angiography Reading Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Rosenfeld+PJ%22">Rosenfeld PJ</searchLink>; Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101589539%22">JAMA ophthalmology</searchLink> [JAMA Ophthalmol] 2017 Jul 01; Vol. 135 (7), pp. 761-767. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101589539 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2168-6173 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221686165%22">21686165 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Ophthalmol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28570723 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1001/jamaophthalmol.2017.1571 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 761 Titles: – TitleFull: Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration: A Phase 1 Dose-Escalation Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jackson TL – PersonEntity: Name: NameFull: Boyer D – PersonEntity: Name: NameFull: Brown DM – PersonEntity: Name: NameFull: Chaudhry N – PersonEntity: Name: NameFull: Elman M – PersonEntity: Name: NameFull: Liang C – PersonEntity: Name: NameFull: O'Shaughnessy D – PersonEntity: Name: NameFull: Parsons EC – PersonEntity: Name: NameFull: Patel S – PersonEntity: Name: NameFull: Slakter JS – PersonEntity: Name: NameFull: Rosenfeld PJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2017 Jul 01 Type: published Y: 2017 Identifiers: – Type: issn-electronic Value: 2168-6173 Numbering: – Type: volume Value: 135 – Type: issue Value: 7 Titles: – TitleFull: JAMA ophthalmology Type: main |
| ResultId | 1 |
